Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives
- 15 May 2021
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 277, 119627
- https://doi.org/10.1016/j.lfs.2021.119627
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patientsCancer Immunology, Immunotherapy, 2013
- Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancerCancer Immunology, Immunotherapy, 2013
- Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast CancerThe Journal of Immunology, 2013
- MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility StudyCancer Prevention Research, 2013
- CD14+S100A9+ Monocytic Myeloid-derived Suppressor Cells and Their Clinical Relevance in Non–Small Cell Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Differential Immunologic and MicroRNA Effects of 2 Dosing Regimens of Recombinant Human Granulocyte/Macrophage Colony Stimulating FactorJournal of Immunotherapy, 2012
- Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patientsCellular Immunology, 2011
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer EnvironmentCancer Research, 2011
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13Cancer Immunology, Immunotherapy, 2011
- Vascular Endothelial Growth Factor-Trap Overcomes Defects in Dendritic Cell Differentiation but Does Not Improve Antigen-Specific Immune ResponsesClinical Cancer Research, 2007